News

Jordan S. Orange, MD, PhD Returns to Leadership Role at CHOP

Jordan S. Orange, MD, PhD Returns to Leadership Role at CHOP

Jordan S. Orange, MD, PhD Takes on New Role at CHOP

Dr. Orange will focus on transformative care and meaningful innovation.

Children's Hospital of Philadelphia (CHOP) has announced that Jordan S. Orange, MD, PhD has rejoined the institution as Pediatrician-in-Chief and Chair of the Department of Pediatrics. In this significant role, he will enhance the pediatric healthcare landscape with a focus on innovation in patient care.

Dr. Orange is an esteemed physician-scientist known for his contributions to understanding pediatric primary immunodeficiencies and the immunobiology of natural killer cells. He completed his pediatric residency at CHOP and previously held the Jeffrey Modell Endowed Chair of Immunology Research, highlighting his remarkable commitment to pediatric healthcare.

Joseph W. St. Geme III, MD, Physician-in-Chief at CHOP, expressed excitement about Dr. Orange's return, stating, "We are thrilled that Dr. Orange has rejoined CHOP. His unparalleled expertise combines clinical and research excellence, which I believe will significantly advance patient care and scientific discovery at our institution.”

Prior to rejoining CHOP, Dr. Orange served as the Reuben S. Carpentier Professor and Chair of the Department of Pediatrics at Columbia University, where he also held the position of Physician-in-Chief at New York Presbyterian Morgan Stanley Children's Hospital. His experience also includes significant roles at Baylor College of Medicine, where he contributed as Professor, Vice Chair for Research, and Chief of Immunology/Allergy/Rheumatology. His leadership at the Center for Human Immunobiology at Texas Children's Hospital showcases his extensive background in healthcare leadership.

Dr. Orange's research career stands out, having made pivotal contributions to immunology. His work has illuminated intercellular immune interactions and the nature of immune diseases through critical insights gained from studying inborn errors of immunity. Notably, he has contributed to the identification of 29 novel genetic diseases that emerged from his laboratory. His dedication to advancing the field is underscored by consistent NIH funding and an impressive portfolio of over 350 publications, leading to a remarkable h-index of 96.

In his own words, Dr. Orange stated, "Advancing our work at CHOP is a profound honor. I am thrilled to be back in this exceptional environment, where our unparalleled infrastructure and unique expertise in rare disease care allow us to potentially redefine success in children's health.”

He completed his academic journey with a baccalaureate and MD/PhD from Brown University, followed by a pediatric residency at CHOP and an Allergy/Immunology/Rheumatology fellowship at Boston Children's Hospital. His accolades include several prestigious awards such as the Judson Daland Prize and the E. Mead Johnson Award, accentuating his contributions to pediatric medicine.

About Children's Hospital of Philadelphia
Children's Hospital of Philadelphia is a renowned non-profit hospital founded in 1855, recognized as the first pediatric hospital in the United States. CHOP is dedicated to delivering exceptional patient care, educating the next generation of providers, and engaging in major research initiatives that have led to remarkable advances benefitting children all over the world. Hosting one of the largest pediatric research programs nationally, the hospital is also known for its extensive CHOP Care Network, providing advanced care through more than 50 practices and specialized centers across several regions.

The institution also operates vital facilities like the Middleman Family Pavilion and its Behavioral Health and Crisis Center, ensuring comprehensive care for pediatric patients. With a strong focus on family-centered care and advocacy, CHOP remains a leading force in promoting children's health and well-being.

Contact: Ashley Moore
Children's Hospital of Philadelphia
267-426-6071

Frequently Asked Questions

What is Dr. Jordan S. Orange's new role at CHOP?

Dr. Orange has rejoined CHOP as Pediatrician-in-Chief and Chair of the Department of Pediatrics.

What are Dr. Orange's notable contributions to immunology?

He has made significant advancements in understanding pediatric primary immunodeficiencies and has played a crucial role in discovering novel genetic diseases.

What educational background does Dr. Orange have?

Dr. Orange completed his MD/PhD at Brown University and his pediatric residency at CHOP.

What accolades has Dr. Orange received?

Dr. Orange has received various prestigious awards, including the Judson Daland Prize and the E. Mead Johnson Award.

What is CHOP's commitment to pediatric healthcare?

CHOP is dedicated to providing exceptional patient care, education for future healthcare professionals, and pioneering research initiatives for children's health improvement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 9

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 4

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

Nvidia's Skyrocketing Stock: Comparing With Bitcoin Returns

Updated Category News Views 155

Nvidia's Remarkable Growth in the Stock Market Nvidia Corp., famously led by CEO Jensen Huang, continues to impress investors with its exceptional financial performance, especially in the realm of artificial intelligence (AI). Recently, the company announced a staggering third-quarter revenue of $35.1 billion, coupled with earnings per share of 81 cents, surpassing...

Continue Reading
Celebrating Katharine Morgan: A Pioneer Award for Leadership

Updated Category News Views 181

Katharine Morgan's retirement from ASTM International was a watershed moment back in 2023. The organization wasn't just losing a president; it was saying goodbye to a true pioneer in the field of standardization. She’d kicked off her journey way back in 1984 and climbed the ranks like a seasoned pro, ultimately becoming the first female president of ASTM. Now that’s...

Continue Reading
Arcadis Transitions to New CFO: Willem Baars Steps Up

Updated Category News Views 524

Arcadis Announces CFO Transition: A New Chapter Begins Arcadis, recognized as a global leader in sustainable design, engineering, and consultancy solutions, is undergoing a significant transition in its executive leadership. Virginie Duperat-Vergne will step down as Chief Financial Officer (CFO) and a member of the Executive Board, effective from 31 May 2025. This...

Continue Reading
The BLVD Group Launches Major Affordable Housing Project

Updated Category News Views 289

The BLVD Group Launches Major Affordable Housing Project The BLVD Group, renowned for its commitment to creating affordable housing, is thrilled to announce an innovative redevelopment initiative. They are set to enhance Concord Royal Gardens, a significant 300-unit affordable housing community, with a total investment of $97 million. This endeavor, which involves...

Continue Reading
Altimmune Unveils Pemvidutide Clinical Data at Diabetes Meeting

Updated Category News Views 63

Altimmune Showcases Pemvidutide at European Diabetes Conference Altimmune, Inc. (Nasdaq: ALT), a leading clinical-stage biopharmaceutical company, has announced an exciting development regarding its innovative treatment, pemvidutide. The company is preparing to present significant findings from its Phase 2 clinical study at the esteemed 60th Annual Meeting of the European...

Continue Reading